Navigation Links
Don't Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire/ -- Future Pharmaceuticals features an exclusive interview with Dave Champagne, Vice President and General Manager of Informatics at Thermo Fisher Scientific, and Thor-Gunnar Steinsli, LIMS Manager and Chief Engineer at HUNT Research Center and Biobank, about data integration: the benefits of data, instrument and enterprise integration strategies and challenges at life sciences companies.

"One of the biggest challenges facing life sciences companies has to do with managing the ever-growing volume of data and connecting all of the disparate sources of data throughout an organization," Champagne said.

"HUNT Biobank is a vivid example of the benefits of this type of integrated solution who helped us secure Microsoft's prestigious Pharmaceutical and Life Sciences Innovation Award in Discovery and Product Innovation (for more information visit http://www.thermo.com/informatics)," Champagne added.

The Director of Global Quality Labs at Eli Lilly, Jackie Larew, is featured in this issue leading an expert panel around issues facing the supply chain. One of the questions she poses to the panel is around the recent concerns we've seen with pet food and milk products tainted with melamine and contaminated heparin entering the U.S. supply chain. "What implications does this have for the way pharmaceutical companies ensure quality from their suppliers with an increasingly global supply chain of raw materials?" Larew asked the panelists.

This edition of FP also delves into the changing world of cell-based therapy. Mark Thiede, Research Fellow with Pfizer for the Genetically Modified Models Center of Emphasis, guest moderates a panel discussion on the future of the cellular therapy industry. Read the piece, Diagnosis: Cell-based Therapy, for their insights.

About Future Pharmaceuticals

Future Pharmaceuticals magazine draws connections between industry leaders and pharmaceutical companies. Future Pharmaceuticals recommends next generation and groundbreaking strategies to ensure success across the enterprise.

About Analysts In Media

AIM Inc., headquartered in New York City, is a leading global provider of high-quality, comprehensive information for the professional and enthusiast markets. Through progressive research, surveys and client case studies from visionaries and leaders in the industry, AIM provides access to its validated knowledge via targeted multi-media channels, publications, events and online services.

For more information, visit www.FuturePharmaUS.com


'/>"/>
SOURCE Future Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
2. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
3. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
4. Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline
5. California Life Science, Business, and Economic Development Experts Discuss Californias Bioscience Future
6. New nanolaser key to future optical computers and technologies
7. Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
8. Industry Leaders Will Gather to Discuss the Future of the "Hydrogen Economy" in Washington DC
9. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
10. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
11. Health Strategies Group Forecasts Emerging Trends in Future Sales Force Models at the SPBT 2009 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... LONDON and NEW YORK ... at HIMSS, Lumeon , a leading digital ... (DN Telehealth), a provider of telemedicine and remote ... care pathways for telemedicine reimbursements.  ... and their patients, in real-time, extending consultations beyond ...
(Date:2/23/2017)... ATLANTA , Feb. 23, 2017  In Atlanta, it ... art, fashion, and culture intertwine to create an expressive and ... often reflect this energy and contribute to it. ... , Hair Fairies seeks to carry on that ... The Atlanta salon is the newest ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... the 12th annual Inventors Recognition Reception at Purdue Research Park of ... faculty member in recognition of outstanding contributions to, and success with, commercializing discoveries ...
(Date:2/23/2017)... SAN DIEGO and SAN FRANCISCO ... , a privately-held regenerative medicine company, and Beyond Type ... living with type 1 diabetes, today announced a grant ... develop a functional cure for type 1 and other ... decade, ViaCyte has been developing innovative stem cell-derived cell ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
(Date:1/24/2017)... 24, 2017 Biopharm Reports has carried ... use of nuclear magnetic resonance spectroscopy (NMR). This ... profiled current practices, developments, trends and end-user plans ... growth and opportunities. These areas include growth in ... needs and innovation requirements, hyphenated NMR techniques, main ...
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Biometrics Market 2017-2021" report to their offering. ... The global voice recognition biometrics ... 2017-2021. The report covers the present scenario and ... 2017-2021. To calculate the market size, the report considers the revenue ...
Breaking Biology News(10 mins):